Scott Sieckert

Scott Sieckert is an experienced finance professional currently serving as VP of Finance at Tarsus Pharmaceuticals, Inc. since September 2023. Prior to this role, Scott held the position of Vice President, Global Corporate Controller at Global Blood Therapeutics from August 2021 until its acquisition by Pfizer in October 2022. Previously, Scott was an Executive Director, Corporate Controller at Bristol Myers Squibb during the MyoKardia acquisition and at MyoKardia before its acquisition by Bristol Myers Squibb. Other roles include Treasurer and Board Member for Youth Tennis Advantage, Corporate Controller at Adamas Pharmaceuticals, and a decade-long tenure at EY, where Scott specialized in assurance services for life science companies. Scott holds an MBA in Finance/Accounting from the University of the Pacific and a B.S. in Genetics from the University of California, Davis.